Genmab A/S Files 6-K, Incorporates into S-8 Filings
Ticker: GNMSF · Form: 6-K · Filed: Apr 10, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Apr 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing-update, regulatory, compliance
TL;DR
Genmab filed a 6-K on 4/10/25, updating its S-8 filings. Standard procedure.
AI Summary
Genmab A/S filed a Form 6-K on April 10, 2025, to report information as a foreign private issuer. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
Why It Matters
This filing ensures that Genmab's ongoing registration statements for its equity incentive plans are kept up-to-date with current information, which is crucial for compliance and investor transparency.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would typically indicate a change in risk.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 0001558370-25-004663 (filing_id) — Accession Number
- April 10, 2025 (date) — Filing Date
- Form 6-K (document_type) — Filing Type
- Form S-8 (document_type) — Incorporated Registration Statements
- 333-232693 (registration_number) — S-8 File Number
- 333-253519 (registration_number) — S-8 File Number
- 333-262970 (registration_number) — S-8 File Number
- 333-277273 (registration_number) — S-8 File Number
- 333-284876 (registration_number) — S-8 File Number
FAQ
What is the purpose of this Form 6-K filing by Genmab A/S?
The Form 6-K is filed by Genmab A/S to report information as a foreign private issuer and is incorporated by reference into its existing S-8 registration statements.
When was this Form 6-K filed by Genmab A/S?
This Form 6-K was filed on April 10, 2025.
Which registration statements does this 6-K filing get incorporated into?
This filing is incorporated into Genmab A/S's registration statements on Form S-8, specifically File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What is the SIC code for Genmab A/S?
The Standard Industrial Classification (SIC) code for Genmab A/S is 2834, which corresponds to Pharmaceutical Preparations.
What is the principal executive office address for Genmab A/S?
The principal executive offices of Genmab A/S are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2025 regarding GENMAB A/S (GNMSF).